Back
Credit Suisse Asset Management Income Fund Inc. Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Sell
40
CIK
Credit Suisse Asset Management Income Fund Inc.
Last Price:
$2.82
Seasonality Move:
2.58%
Buy
52
RNA
Avidity Biosciences, Inc.
Last Price:
$72.32
Seasonality Move:
29.53%
Sell
40
Credit Suisse Asset Management Income Fund Inc. (CIK)
is a Sell
Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?
-
The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.82. The Score for CIK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $72.34. The Score for RNA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CIK Stock Price Chart
What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?
-
The Credit Suisse Asset Management Income Fund Inc. share price today is $2.82The current trend is relatively stagnant and CIK is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $72.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
CIK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.69 | Sell |
| Chaikin Money Flow: | 314437 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.79 - 2.83) | Buy |
| Bollinger Bands (100): | (2.82 - 2.98) | Sell |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.57 | Buy |
| Relative Strength Index (14 RSI): | 77.3 | Buy |
| Chaikin Money Flow: | 547948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.95 - 71.89) | Buy |
| Bollinger Bands (100): | (42.54 - 68.1) | Buy |
CIK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.81 | Buy |
| 20-day SMA: | 2.81 | Buy |
| 50-day SMA: | 2.84 | Sell |
| 200-day SMA: | 2.89 | Sell |
| 8-day EMA: | 2.81 | Buy |
| 20-day EMA: | 2.82 | Buy |
| 50-day EMA: | 2.84 | Sell |
| 200-day EMA: | 2.9 | Sell |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.87 | Buy |
| 20-day SMA: | 71.59 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 42.99 | Buy |
| 8-day EMA: | 38.2 | Buy |
| 20-day EMA: | 18.71 | Buy |
| 50-day EMA: | 8.16 | Buy |
| 200-day EMA: | 2.13 | Buy |
Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
Credit Suisse Asset Management Income Fund Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||